Basilea Pharmaceutica AG (BSLN) — Net Asset Quality Index
Basilea Pharmaceutica AG (BSLN) has a Net Asset Quality Index of 45.4% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CHF282.00 Million minus total liabilities of CHF154.06 Million yields net assets of CHF127.94 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check BSLN cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Basilea Pharmaceutica AG Net Asset Quality Index Over Time (2002–2025)
This chart shows how Basilea Pharmaceutica AG's Net Asset Quality Index has evolved across 24 annual periods from 2002 to 2025. As of December 2025, the index stands at 45.4%, representing net assets of CHF127.94 Million against total assets of CHF282.00 Million CHF. See BSLN working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Basilea Pharmaceutica AG (2002–2025)
The table below presents the year-by-year Net Asset Quality Index for Basilea Pharmaceutica AG from 2002 to 2025, covering 24 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Basilea Pharmaceutica AG stock valuation.
| Year | Quality Index | Net Assets (CHF) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 45.4% | CHF127.94 Million | CHF282.00 Million | CHF154.06 Million | ▲ +13.9 pp |
| 2024 | 31.4% | CHF81.00 Million | CHF257.76 Million | CHF176.76 Million | ▲ +37.2 pp |
| 2023 | -5.8% | CHF-10.00 Million | CHF173.29 Million | CHF183.29 Million | ▲ +3.6 pp |
| 2022 | -9.4% | CHF-20.71 Million | CHF220.85 Million | CHF241.56 Million | ▲ +14.3 pp |
| 2021 | -23.7% | CHF-58.61 Million | CHF247.27 Million | CHF305.87 Million | ▲ +20.7 pp |
| 2020 | -44.4% | CHF-102.05 Million | CHF229.79 Million | CHF331.84 Million | ▼ -2.4 pp |
| 2019 | -42.0% | CHF-92.96 Million | CHF221.47 Million | CHF314.43 Million | ▼ -18.3 pp |
| 2018 | -23.7% | CHF-66.69 Million | CHF281.75 Million | CHF348.44 Million | ▼ -11.9 pp |
| 2017 | -11.8% | CHF-41.44 Million | CHF351.17 Million | CHF392.61 Million | ▼ -1.1 pp |
| 2016 | -10.7% | CHF-35.00 Million | CHF327.76 Million | CHF362.76 Million | ▼ -14.4 pp |
| 2015 | 3.7% | CHF14.86 Million | CHF398.74 Million | CHF383.88 Million | ▼ -18.8 pp |
| 2014 | 22.5% | CHF57.93 Million | CHF257.38 Million | CHF199.45 Million | ▼ -1.1 pp |
| 2013 | 23.6% | CHF70.87 Million | CHF299.76 Million | CHF228.88 Million | ▼ -4.5 pp |
| 2012 | 28.1% | CHF105.50 Million | CHF375.34 Million | CHF269.84 Million | ▼ -36.5 pp |
| 2011 | 64.6% | CHF153.27 Million | CHF237.09 Million | CHF83.82 Million | ▼ -1.8 pp |
| 2010 | 66.4% | CHF210.24 Million | CHF316.54 Million | CHF106.30 Million | ▲ +19.1 pp |
| 2009 | 47.3% | CHF97.73 Million | CHF206.61 Million | CHF108.88 Million | ▼ -13.6 pp |
| 2008 | 60.9% | CHF199.74 Million | CHF328.13 Million | CHF128.38 Million | ▼ -11.7 pp |
| 2007 | 72.6% | CHF335.10 Million | CHF461.45 Million | CHF126.34 Million | ▲ +17.3 pp |
| 2006 | 55.3% | CHF112.31 Million | CHF203.09 Million | CHF90.78 Million | ▼ -10.4 pp |
| 2005 | 65.7% | CHF167.87 Million | CHF255.56 Million | CHF87.69 Million | ▼ -25.1 pp |
| 2004 | 90.8% | CHF209.60 Million | CHF230.78 Million | CHF21.18 Million | ▲ +6.5 pp |
| 2003 | 84.4% | CHF90.29 Million | CHF107.02 Million | CHF16.73 Million | ▲ +1.1 pp |
| 2002 | 83.3% | CHF125.38 Million | CHF150.51 Million | CHF25.13 Million | — |